Jennifer Chien joined Rhythm Pharmaceuticals in November 2020 as Executive Vice President North America. Jennifer brings more than 20 years of strategy and commercial experience in rare diseases. Most recently, she was the Chief Commercial Officer at Krystal Biotech. Prior to that, she served as Vice President, Head of Genetic Diseases at Sanofi Genzyme, where she was responsible for the U.S. commercial strategy and implementation for seven brands and launch preparation within rare diseases. During her time at Sanofi Genzyme, Jennifer also held leadership roles as Vice President, Head of Global Nephrological Diseases, Senior Director of Global Marketing in Fabry disease, Senior Director of Global Market Access and International Marketing for the cardiovascular business, and Director of Business Development. Jennifer holds a Bachelor of Science degree from Massachusetts Institute of Technology and a master’s in public health from Harvard University.
Senior Management
-
David Meeker, MD
Chairman, President
and Chief Executive Officer -
Jennifer Chien
Executive Vice President,
Head of North America -
Simon D. Kelner
Chief Human Resources
Officer -
Yann Mazabraud
Executive Vice President,
Head of International -
Hunter Smith
Chief Financial
Officer -
Murray Stewart, MD
Chief Medical
Officer -
Satej Bhandarkar
Senior Vice-President, Program Management, Strategy and Corporate Development -
Jim Flaherty
Senior Vice President
and General Counsel -
Alastair Garfield
Vice President,
Head of Research -
Joe Shulman
Senior Vice President,
Technical Operations -
Irene Aquino
Vice President, Patient Engagement
Advocacy and Support -
Brieana Buckley
Vice President,
Medical Affairs -
Gregory Gordon
Vice President,
Clinical -
Joanne E. Totosy de Zepetnek
Vice President,
Regulatory Affairs and Quality